{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:17:32Z","timestamp":1791944252496,"version":"4.3.4"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,25]]},"DOI":"10.18632\/oncotarget.17693","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T17:36:11Z","timestamp":1494264971000},"page":"49757-49772","source":"Crossref","is-referenced-by-count":20,"title":["Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients"],"prefix":"10.18632","volume":"8","author":[{"given":"Wei-Jie","family":"Zhong","sequence":"first","affiliation":[{"name":"Department of Hematology & Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology & Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China"},{"name":"Immunology Institute, Mount Sinai School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology & Oncology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Hua","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Pathology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China"},{"name":"Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Esophageal Cancer Institute, Cancer Center, Sun Yat-Sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ying","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Bao","family":"Xiong","sequence":"additional","affiliation":[{"name":"Immunology Institute, Mount Sinai School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Shan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/107327481201900305","article-title":"Diffuse large B-cell lymphoma: current strategies and future directions","volume":"19","author":"Dalia","year":"2012","journal-title":"Cancer Control"},{"key":"2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5858\/2008-132-118-DLBL","article-title":"Diffuse large B-cell lymphoma","volume":"132","author":"Reichard","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"101","key":"3","first-page":"78","article-title":"Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma","volume":"2003","author":"Campo","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00108-015-0007-5","article-title":"Current therapeutic strategies for diffuse large B cell lymphoma","volume":"57","author":"Pfreundschuh","year":"2016","journal-title":"Internist (Berl)"},{"issue":"60","key":"5","first-page":"393","article-title":"Improving outcomes for patients with diffuse large B-cell lymphoma","volume":"2010","author":"Vose","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"6","first-page":"995","article-title":"Prognostic biomarkers in diffuse large B-cell lymphoma","volume":"2006","author":"Morgensztern","journal-title":"J Clin Oncol"},{"issue":"6","key":"7","first-page":"1123","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"2005","author":"Weaver","journal-title":"Nat Immunol"},{"issue":"453","key":"8","first-page":"1051","article-title":"Induction and effector functions of T(H)17 cells","volume":"2008","author":"Kuchroo","journal-title":"Nature"},{"issue":"441","key":"9","first-page":"235","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"2006","author":"Kuchroo","journal-title":"Nature"},{"issue":"24","key":"10","first-page":"179","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"2006","author":"Stockinger","journal-title":"Immunity"},{"issue":"126","key":"11","first-page":"1121","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"2006","author":"Littman","journal-title":"Cell"},{"issue":"287","key":"12","first-page":"35484","article-title":"Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients","volume":"2012","author":"Zeng","journal-title":"J Biol Chem"},{"issue":"71","key":"13","first-page":"1263","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"2011","author":"Galon","journal-title":"Cancer Res"},{"issue":"12","key":"14","first-page":"7424","article-title":"Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients","volume":"2011","author":"Li","journal-title":"Int J Mol Sci"},{"issue":"105","key":"15","first-page":"15505","article-title":"Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer","volume":"2008","author":"Wang","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"16","first-page":"e24622","article-title":"Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma","volume":"2011","author":"Fisson","journal-title":"Plos One"},{"issue":"69","key":"17","first-page":"5522","article-title":"Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma","volume":"2009","author":"Ansell","journal-title":"Cancer Res"},{"issue":"11","key":"18","first-page":"e148044","article-title":"Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma","volume":"2016","author":"Ji","journal-title":"Plos One"},{"issue":"9","key":"19","first-page":"269","article-title":"IRF4 and IRF8: Governing the virtues of B Lymphocytes","volume":"2014","author":"Lu","journal-title":"Front Biol (Beijing)"},{"issue":"87","key":"20","first-page":"307","article-title":"Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene","volume":"1996","author":"Morse","journal-title":"Cell"},{"issue":"170","key":"21","first-page":"6329","article-title":"Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma","volume":"2003","author":"Abrams","journal-title":"J Immunol"},{"issue":"32","key":"22","first-page":"1190","article-title":"Expression of the interferon regulatory factor 8\/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker","volume":"2008","author":"Raffeld","journal-title":"Am J Surg Pathol"},{"issue":"122","key":"23","first-page":"726","article-title":"A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma","volume":"2013","author":"Aguiar","journal-title":"Blood"},{"issue":"55","key":"24","first-page":"136","article-title":"IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1)","volume":"2014","author":"Zimmermann","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"25","first-page":"953","article-title":"Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma","volume":"2015","author":"Zhou","journal-title":"J Cancer"},{"issue":"2","key":"26","first-page":"314","article-title":"Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation","volume":"2011","author":"Lira","journal-title":"Nat Commun"},{"issue":"195","key":"27","first-page":"1480","article-title":"Dual Function of the IRF8 Transcription Factor in Autoimmune Uveitis: Loss of IRF8 in T Cells Exacerbates Uveitis, Whereas Irf8 Deletion in the Retina Confers Protection","volume":"2015","author":"Egwuagu","journal-title":"J Immunol"},{"issue":"40","key":"28","first-page":"187","article-title":"The transcription factor IRF8 activates integrin-mediated TGF-beta signaling and promotes neuroinflammation","volume":"2014","author":"Wang","journal-title":"Immunity"},{"issue":"403","key":"29","first-page":"503","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"2000","author":"Marti","journal-title":"Nature"},{"issue":"182","key":"30","first-page":"10","article-title":"The role and regulation of human Th17 cells in tumor immunity","volume":"2013","author":"Peng","journal-title":"Am J Pathol"},{"issue":"114","key":"31","first-page":"1141","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"2009","author":"Liu","journal-title":"Blood"},{"issue":"185","key":"32","first-page":"998","article-title":"IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response","volume":"2010","author":"Kienzle","journal-title":"J Immunol"},{"issue":"184","key":"33","first-page":"1630","article-title":"Tumor microenvironments direct the recruitment and expansion of human Th17 cells","volume":"2010","author":"Peng","journal-title":"J Immunol"},{"issue":"110","key":"34","first-page":"2537","article-title":"CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells","volume":"2007","author":"Ansell","journal-title":"Blood"},{"issue":"201","key":"35","first-page":"127","article-title":"Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus","volume":"2005","author":"Kosiewicz","journal-title":"J Exp Med"},{"issue":"179","key":"36","first-page":"4775","article-title":"IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of Fas expression","volume":"2007","author":"Liu","journal-title":"J Immunol"},{"issue":"16","key":"37","first-page":"R117","article-title":"Decreased interleukin 27 expression is associated with active uveitis in Behcet's disease","volume":"2014","author":"Yang","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"38","first-page":"1841","article-title":"DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells","volume":"2008","author":"Liu","journal-title":"Mol Cancer Res"},{"issue":"354","key":"39","first-page":"227","article-title":"Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis","volume":"2014","author":"Jin","journal-title":"Cancer Lett"},{"issue":"183","key":"40","first-page":"3188","article-title":"IFN regulatory factor 8 regulates MDM2 in germinal center B cells","volume":"2009","author":"Morse","journal-title":"J Immunol"},{"issue":"12","key":"41","first-page":"366","article-title":"IL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis","volume":"2015","author":"Xiong","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"42","first-page":"e1030560","article-title":"Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma","volume":"2015","author":"Pistoia","journal-title":"Oncoimmunology"},{"issue":"145","key":"43","first-page":"514","article-title":"Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy","volume":"2016","author":"Inamdar","journal-title":"Am J Clin Pathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T09:59:00Z","timestamp":1659002340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":43,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,7,25]]}},"alternative-id":["17693","28537908"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17693","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]}}}